Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
14 hedge funds and large institutions have $540K invested in Timber Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 7 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
18% less funds holding
Funds holding: 17 → 14 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
80% less capital invested
Capital invested by funds: $2.63M → $540K (-$2.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$177K |
| 2 |
NFG
Nadler Financial Group
Deerfield,
Illinois
|
+$58.5K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$27.3K |
| 5 |
Two Sigma Investments
New York
|
+$24.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$426K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$293K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.68K |
| 5 |
LPL Financial
San Diego,
California
|
-$4K |
TMBR Hedge Fund Activity: Q2 2019 in Review
14 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q2 2019, worth a combined $540K — down 80% from $2.63M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of TMBR and 4 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Virtu Financial, adding an estimated $177K. The largest seller was Vivo Capital, cutting an estimated $426K.
- 14 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q2 2019, down from 17 in Q1 2019.
- Funds reported $540K of Timber Pharmaceuticals, Inc. stock for Q2 2019, down 80% quarter-over-quarter.
- 4 funds opened new Timber Pharmaceuticals, Inc. positions in Q2 2019 and 7 closed out, a net change of -3 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q2 2019 was Virtu Financial, an estimated $177K added.
- The largest Timber Pharmaceuticals, Inc. seller in Q2 2019 was Vivo Capital, an estimated $426K sold.
Based on aggregated 13F filings for Q2 2019.